How did Accenture perform in Q2 FY2026?

A clean beat with accelerating growth. Revenue came in at $18.04B vs estimates of ~$17.6B (+2.5% beat), up +8.3% YoY. EPS of $2.93 beat prior year's $2.63 by +11.4%. Operating margin expanded from 12.9% to 13.8% — improving profitability alongside growth. Free cash flow surged +36.7% YoY to $3.67B, the strongest signal in the quarter. GenAI bookings are accelerating, which is the forward-looking indicator the market cares most about.

What is driving Accenture's GenAI bookings acceleration?

Enterprise clients are moving from GenAI experimentation to deployment at scale — and Accenture is the primary implementation partner for large organizations doing this. The bookings acceleration reflects enterprises committing to multi-year GenAI transformation programs (ERP modernization, workflow automation, custom model deployment) rather than one-off pilots. Accenture sits between the model providers (Microsoft, Google, Anthropic) and the enterprise clients who need the actual integration work done. That's a durable position.

Why is free cash flow the strongest signal in the quarter?

Free cash flow of $3.67B (+36.7% YoY) shows that revenue growth is converting into actual cash — not just accounting revenue. For a professional services firm, FCF is the cleanest measure of business health because it's harder to inflate than EPS. A 36.7% YoY increase while revenue grew 8.3% means cash conversion improved significantly: fewer receivables outstanding, better client payment terms, or lower capex needs. All are good signs.

How does Accenture's margin expansion fit the broader IT services picture?

Operating margin expanding from 12.9% to 13.8% while growing 8.3% YoY is the combination the market rewards: scale leverage working as expected. Most IT services firms face margin pressure from talent costs, especially in AI-skilled roles. Accenture is managing to expand margins despite elevated hiring and compensation costs for AI/cloud talent — suggesting either pricing power on engagements (clients paying more for GenAI work) or operational efficiency improvements.

What is the consensus outlook for ACN for full-year FY2026?

After the Q2 beat, consensus is coalescing around $74.7B revenue and $13.98 EPS for full-year FY2026. With Buy consensus and an average PT of $287 against a $203.55 close (+4.3%), analysts see roughly 40% upside from current levels. The thesis: GenAI bookings convert to revenue over 12-24 months, driving re-acceleration in the second half of FY2026 and into FY2027.

Why is the +4.3% stock reaction relatively modest for a beat of this quality?

Accenture is a $130B+ market cap company. A 4.3% move on a good print is actually healthy — the stock doesn't have the volatility of a smaller-cap name. More importantly, the market had partially priced in a beat given the revenue re-acceleration narrative that had been building since Q1. The FCF number and GenAI bookings commentary are what sustain the move rather than an initial spike — this is a stock that grinds higher on execution, not one that gaps 10% on earnings.

Accenture Q2 FY2026 Recap: Clean Beat, GenAI Bookings Accelerating, +4.3%

Accenture reported Q2 FY2026 (quarter ending February 28, 2026) before the market open on March 19, delivering a clean beat across all key metrics with a standout free cash flow quarter.

The Numbers

Metric	Actual	Estimate / Prior Year	Result
Revenue	$18.04B	~$17.6B est	Beat (+2.5%)
Revenue YoY	+8.3%	—	Re-accelerating
EPS (diluted)	$2.93	$2.63 (prior year)	+11.4% YoY
Operating income	$2.49B	—	—
Operating margin	13.8%	12.9% prior year	+90 bps expansion
Net income	$1.83B	—	+2.1% YoY
Free cash flow	$3.67B	—	+36.7% YoY
Gross margin	30.3%	30.9% prior year	-60 bps (cost of revenue)

Stock Reaction

Timing	Price	Move
Close, March 19	$203.55	+4.3%
Analyst avg. PT	$287.00	Consensus: Buy

The Signal: Free Cash Flow +36.7% YoY

Revenue grew 8.3%. FCF grew 36.7%. That gap is the story — cash conversion improved significantly. For a professional services firm that books large multi-year contracts, strong FCF means clients are paying on time, project margins are holding, and the business is running efficiently. This is the cleanest indicator in the quarter.

GenAI Bookings: The Forward-Looking Number

Accenture is the dominant implementation partner for enterprise GenAI deployments. When enterprises move beyond pilots to full-scale transformation programs — integrating models into ERP, automating workflows, deploying custom AI infrastructure — they call Accenture.

The bookings acceleration in Q2 tells us two things:

Enterprise AI spending is inflecting from experimentation to commitment
Accenture is capturing that spend at the margin

Bookings today become revenue over the next 12-24 months, which is why analysts are projecting revenue re-acceleration in H2 FY2026 and into FY2027 ($74.7B full-year consensus, $13.98 EPS).

Margin Expansion: The Structural Story

Operating margin went from 12.9% to 13.8% while growing at 8.3%. In a quarter where AI talent costs are elevated across the industry, expanding margins alongside revenue growth means one of two things — or both: clients are paying premium prices for GenAI work (pricing power), and Accenture is operating its own business more efficiently at scale. Either justifies the Buy consensus.

Data as of March 19, 2026 — Ray Finance Intelligence